search icon

    Market Snapshot

    • S&P Futures

      3,819

    • Dow Futures

      30,822

    • Nasdaq Futures

      11,785

    blog search icon

    Aptose Biosciences Inc.

    (NASDAQ:APTO)

    $0.82

    $0.01

    1.23%

    Aptose Biosciences Inc. Chart

    APTO Stock Price Today

    Aptose Biosciences Inc. (APTO) stock rallied over 1.23% intraday to trade at $0.82 a share on NASDAQ. The stock opened with a gain of 7.89% at $0.83 and touched an intraday high of $0.83, rising 1.23% against the last close of $0.81. The stock went to a low of $0.793 during the session.

    Stock Snapshot

    $0.81

    Prev. Close

    69.36 Million

    Market Cap

    $0.793

    Day Low

    $0.83

    Open

    92.23 Million

    Number of Shares

    $0.83

    Day High

    -

    P/E ratio

    -0.68

    EPS (TTM)

    0.86

    Cash Flow per Share

    0.54

    Free Float in %

    1.00

    Book Value

    113,996

    Volume

    Aptose Biosciences Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-06$0.83$0.83$0.793$0.82113,996
    2022-07-05$0.76$0.81$0.76$0.8157,400
    2022-07-01$0.75$0.81$0.75$0.8385,300
    2022-06-30$0.78$0.79$0.73$0.74226,800
    2022-06-29$0.81$0.81$0.77$0.7856,100
    2022-06-28$0.81$0.83$0.75$0.8620,300
    2022-06-27$0.85$0.88$0.8$0.81231,400
    2022-06-24$0.82$0.85$0.82$0.85241,100
    2022-06-23$0.8$0.83$0.78$0.8122,800
    2022-06-22$0.84$0.86$0.79$0.81376,900

    Contact Details

    251 Consumers Road
    Suite 1105
    Toronto, ON M2J 4R3
    Canada

    Webiste:APTO

    Company Information

    Employees-

    Beta1.6

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

    Frequently Asked Questions

    icon

    What is the current Aptose Biosciences Inc. (APTO) stock price?

    Aptose Biosciences Inc. (NASDAQ: APTO) stock price is $0.82 as of the last check on Wednesday, July 6. During the trading session, APTO stock reached the peak price of $0.83 while $0.793 was the lowest point it dropped to.

    icon

    APTO's industry and sector of operation?

    The NASDAQ listed APTO is part of Biotechnology industry that operates in the broader Health Care sector. Aptose Biosciences Inc. , a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States.

    icon

    Who are the executives of APTO?

    Dr. William G. Rice Ph.D.
    Chairman, Pres & CEO
    Dr. Jotin Marango Ph.D., M.D.
    Sr. VP, CFO, Chief Accounting Officer & Chief Bus. Officer
    Dr. William G. Rice Ph.D.
    Chairman, Pres, CEO & Chief Accounting Officer
    Dr. Rafael Bejar M.D., Ph.D.
    Sr. VP & Chief Medical Officer

    icon

    What is the APTO stock price today?

    APTO stock traded closed the last session at $0.82, which is $0.01 or 1.23% lower than its previous close of $0.81. APTO's current trading price is 11.85% lower than its 52-week high of $3.37 where as its distance from 52-week low of 0.73% is -75.63%.

    icon

    How many employees does APTO have?

    Number of APTO employees currently stands at -. APTO operates from 251 Consumers Road, Suite 1105, Toronto, ON M2J 4R3, Canada.

    icon

    Link for APTO official website?

    Official Webiste of $APTO is: https://www.aptose.com

    icon

    How do I contact APTO?

    APTO could be contacted at APTO operates from 251 Consumers Road, Suite 1105, Toronto, ON M2J 4R3, Canada, or at phone # and can also be accessed through its website.

    icon

    How many shares of APTO are traded daily?

    APTO stock volume for the day was 113,996 shares while in the previous session number of APTO shares traded was 113,996 . The average number of APTO shares traded daily for last 3 months was 366.17 Thousands.

    icon

    How much did APTO change today?

    The percentage change in APTO stock occurred in the recent session was 1.23% while the dollar amount for the price change in APTO stock was $0.01.

    icon

    What price range APTO stock been trading in?

    In the recent session, the day high for APTO stock was $0.83 while the low for APTO stock touched on the day was $0.793.

    icon

    What is the market cap of APTO currently?

    The market value of APTO currently stands at 69.36 Million with its latest stock price at $0.82 and 92.23 Million of its shares outstanding.